BA
Brian Abrahams RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
97
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
59.8%
Neutral
39.2%
Negative
1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sector Perform
Maintained
| $23 |
3%
downside
| 4 | -34% |
0
%
| 17 Jul ‘25 5 months ago |
|
|
|
Outperform
Reiterated
| $13 |
76%
upside
| 4 | +3.3% |
0
%
| 30 Jun ‘25 6 months ago |
|
|
|
Sector Perform
Reiterated
| $1.50 |
1,391%
upside
| 1 | – |
–
| 14 May ‘25 8 months ago |
|
|
|
Outperform
Reiterated
| $84 |
256%
upside
| 1 | -27% |
0
%
| 22 Apr ‘25 8 months ago |
|
|
|
Outperform
Initiated
| $31 |
107%
upside
| 1 | +42% |
0
%
| 7 Mar ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $143 |
16%
downside
| 2 | +32% |
0
%
| 3 Feb ‘25 11 months ago |
|
|
|
Outperform
Reiterated
| $40 |
16%
upside
| 1 | +52% |
0
%
| 28 Jan ‘25 11 months ago |
|
|
|
Sector Perform
Downgraded
| $132 |
0%
upside
| 1 | +75% |
–
| 22 Jan ‘25 11 months ago |
|
|
|
Sector Perform
Downgraded
| $1.50 | – | 1 | -61% |
–
| 10 Jan ‘25 1 year ago |
|